GlaxoSmithKline PLC ADR Financial Flexibility Index
GlaxoSmithKline PLC ADR financial flexibility index. GlaxoSmithKline PLC ADR (GSK) has a Financial Flexibility Index of 0.06x as of June 2026. Free cash flow of $2.86 Billion (operating CF $2.54 Billion minus capex $328.95 Million) represents 0% of total liabilities ($44.29 Billion). See GSK FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GlaxoSmithKline PLC ADR (1990–2025)
Financial flexibility index of GlaxoSmithKline PLC ADR from 1990 to 2025. Historical Financial Flexibility Index trend for GlaxoSmithKline PLC ADR across 36 annual periods. Check GSK cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
GlaxoSmithKline PLC ADR Financial Flexibility Index by Year (1990–2025)
GlaxoSmithKline PLC ADR financial flexibility index by year from 1990 to 2025. Year-by-year free cash flow to debt coverage for GlaxoSmithKline PLC ADR. For the full cash flow conversion analysis, see cash efficiency ratio of GlaxoSmithKline PLC ADR.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $8.46 Billion | $7.14 Billion | $45.02 Billion | ▼ -8.6% |
| 2024 | 0.21x | $9.54 Billion | $6.55 Billion | $46.38 Billion | ▲ +27.2% |
| 2023 | 0.16x | $9.52 Billion | $7.89 Billion | $58.91 Billion | ▼ -16.2% |
| 2022 | 0.19x | $9.66 Billion | $7.40 Billion | $50.05 Billion | ▲ +38.8% |
| 2021 | 0.14x | $10.88 Billion | $7.95 Billion | $78.23 Billion | ▲ +6.2% |
| 2020 | 0.13x | $10.68 Billion | $8.44 Billion | $81.50 Billion | ▲ +4.6% |
| 2019 | 0.13x | $10.18 Billion | $8.02 Billion | $81.25 Billion | ▼ -33.3% |
| 2018 | 0.19x | $10.22 Billion | $8.42 Billion | $54.39 Billion | ▲ +8.9% |
| 2017 | 0.17x | $9.12 Billion | $6.92 Billion | $52.89 Billion | ▲ +5.5% |
| 2016 | 0.16x | $8.85 Billion | $6.50 Billion | $54.12 Billion | ▲ +63.0% |
| 2015 | 0.10x | $4.47 Billion | $2.57 Billion | $44.57 Billion | ▼ -48.3% |
| 2014 | 0.19x | $6.93 Billion | $5.18 Billion | $35.72 Billion | ▼ -25.5% |
| 2013 | 0.26x | $8.92 Billion | $7.22 Billion | $34.27 Billion | ▲ +53.4% |
| 2012 | 0.17x | $5.89 Billion | $4.38 Billion | $34.73 Billion | ▼ -27.8% |
| 2011 | 0.23x | $7.58 Billion | $6.25 Billion | $32.25 Billion | ▼ -10.0% |
| 2010 | 0.26x | $8.43 Billion | $6.80 Billion | $32.31 Billion | ▼ -13.7% |
| 2009 | 0.30x | $9.71 Billion | $7.84 Billion | $32.12 Billion | ▲ +0.2% |
| 2008 | 0.30x | $9.38 Billion | $7.31 Billion | $31.07 Billion | ▼ -23.4% |
| 2007 | 0.39x | $8.31 Billion | $6.17 Billion | $21.09 Billion | ▲ +10.5% |
| 2006 | 0.36x | $5.67 Billion | $4.08 Billion | $15.90 Billion | ▼ -5.2% |
| 2005 | 0.38x | $7.38 Billion | $6.20 Billion | $19.63 Billion | ▲ +23.0% |
| 2004 | 0.31x | $5.20 Billion | $4.94 Billion | $17.01 Billion | ▼ -20.0% |
| 2003 | 0.38x | $5.91 Billion | $4.85 Billion | $15.49 Billion | ▲ +33.0% |
| 2002 | 0.29x | $4.29 Billion | $3.06 Billion | $14.94 Billion | ▼ -32.0% |
| 2001 | 0.42x | $5.73 Billion | $4.61 Billion | $13.57 Billion | ▲ +80.5% |
| 2000 | 0.23x | $2.96 Billion | $1.85 Billion | $12.63 Billion | ▲ +52.8% |
| 1999 | 0.15x | $1.11 Billion | $510.00 Million | $7.23 Billion | ▲ +13.7% |
| 1998 | 0.13x | $885.00 Million | $410.00 Million | $6.58 Billion | ▼ -14.5% |
| 1997 | 0.16x | $1.03 Billion | $615.00 Million | $6.55 Billion | ▼ -11.3% |
| 1996 | 0.18x | $1.25 Billion | $849.00 Million | $7.05 Billion | ▼ -23.8% |
| 1995 | 0.23x | $1.94 Billion | $1.25 Billion | $8.32 Billion | ▼ -40.3% |
| 1994 | 0.39x | $2.93 Billion | $2.45 Billion | $7.53 Billion | ▼ -34.4% |
| 1993 | 0.59x | $1.63 Billion | $1.05 Billion | $2.74 Billion | ▲ +8.5% |
| 1992 | 0.55x | $1.53 Billion | $927.00 Million | $2.80 Billion | ▼ -10.5% |
| 1991 | 0.61x | $1.25 Billion | $657.00 Million | $2.04 Billion | ▲ +23.5% |
| 1990 | 0.50x | $1.22 Billion | $615.00 Million | $2.46 Billion | — |